Literature DB >> 24998377

Synthesis and biological evaluation of 9α- and 9β-hydroxyamino-parthenolides as novel anticancer agents.

Mohamed Moumou1, Abderrahman El Bouakher2, Hassan Allouchi3, Ahmed El Hakmaoui1, Ahmed Benharref4, Véronique Mathieu5, Gérald Guillaumet6, Mohamed Akssira7.   

Abstract

A series of 9α-hydroxyamino-parthenolides 3-10, 9β-hydroxyamino-parthenolides 11-13 and 9α-hydroxy-1β,10α-epoxyamino-parthenolides 15-19 were efficiently synthesized starting from 9α-hydroxyparthenolide 1 and 9β-hydroxyparthenolide 2, which were isolated from Anvillea radiata. Compounds 1-13 and 15-19 were evaluated for their in vitro anticancer activity by the MTT colorimetric assay against one murine and six human cancer cell lines. This work provides new details about the structural requisites for anticancer activity.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  9-Hydroxyamino-parthenolides; 9-Hydroxyparthenolides; 9α-Hydroxy-1β,10α-epoxyamino-parthenolides; 9α-Hydroxy-1β,10α-epoxyparthenolides; Anticancer activity

Mesh:

Substances:

Year:  2014        PMID: 24998377     DOI: 10.1016/j.bmcl.2014.06.019

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Chemical reactivities and molecular docking studies of parthenolide with the main protease of HEP-G2 and SARS-CoV-2.

Authors:  Abdelhak Ouled Aitouna; M E Belghiti; Aslı Eşme; E Anouar; Anass Ouled Aitouna; A Zeroual; M Salah; A Chekroun; H El Alaoui El Abdallaoui; A Benharref; N Mazoir
Journal:  J Mol Struct       Date:  2021-05-19       Impact factor: 3.196

2.  Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia.

Authors:  Xingjian Li; Daniel T Payne; Badarinath Ampolu; Nicholas Bland; Jane T Brown; Mark J Dutton; Catherine A Fitton; Abigail Gulliver; Lee Hale; Daniel Hamza; Geraint Jones; Rebecca Lane; Andrew G Leach; Louise Male; Elena G Merisor; Michael J Morton; Alex S Quy; Ruth Roberts; Rosanna Scarll; Timothy Schulz-Utermoehl; Tatjana Stankovic; Brett Stevenson; John S Fossey; Angelo Agathanggelou
Journal:  Medchemcomm       Date:  2019-08-01       Impact factor: 3.597

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.